The Promise of Nanomedicine

At AACR, scientists discuss the growing interest in nanotechnology and how it can be used to study, diagnose, and treat cancer.

By | April 8, 2014

WIKIMEDIA, NEMISSIMOOnly a handful of nanotherapeutics are currently on the market, but dozens more are making their way through preclinical studies and clinical trials. And the more researchers learn about the new technology, the more excited they get. In a session today (April 8) at this year's American Association for Cancer Research (AACR) meeting, researchers discussed the promises—and challenges—of this growing field.

“[Nanotechnology is] allowing people to do science, and look at cancer, in fundamentally new ways,” said James Heath of Caltech. In addition to treating disease, the panelists noted, nanotechnology could improve early-stage diagnosis and even help predict the development of drug resistance in tumors. “Success in early detection has been limited at best,” said Anil Sood from the University of Texas MD Anderson Cancer Center. “Nanotechnology offers a variety of opportunities in detection and screening.”

Mark Davis, also from Caltech, emphasized the so-far impressive safety profiles of nanotherapeutics. “With well-designed particles . . . the idea is less drug, less often, greater efficacy.” The safety profiles of some nanomedicines are so good, in fact, that researchers are able to maintain dose levels even when combined with other therapies, he noted, and studies are beginning to show evidence of long-term safety. “It’s very clear [that these products have] dramatically reduced side effects” as compared with traditional therapies, he said. “This is going to open up a lot of different combination therapies now that we couldn't do in the past.”

Amid the excitement, however, were also words of caution. “The environment is a difficult one,” said Paul Burke, principal of Burke Bioventures. “Attrition rates are high and they're getting higher. . . . There are no special rules—no grading on a curve—just because nanotechnology is exciting.”

Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo
Horizon Discovery
Horizon Discovery

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  3. Holding Their Ground
    Features Holding Their Ground

    To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

  4. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

Life Technologies